Shockwave Medical, Inc. (SWAV)
May 31, 2024 - SWAV was delisted (reason: acquired by JNJ)
334.75
0.00 (0.00%)
Inactive · Last trade price on May 30, 2024

Company Description

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally.

The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.

It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina.

In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions.

Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves.

It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors.

The company was incorporated in 2009 and is headquartered in Santa Clara, California. As of May 31, 2024, Shockwave Medical, Inc. operates as a subsidiary of Johnson & Johnson.

Shockwave Medical, Inc.
ShockWave Medical logo
CountryUnited States
Founded2009
IPO DateMar 7, 2019
IndustryMedical Devices
SectorHealthcare
Employees1,468
CEODouglas E. Godshall M.B.A.

Contact Details

Address:
5403 Betsy Ross Drive
Santa Clara, Delaware 95054
United States
Phone510 279 4262
Websiteshockwavemedical.com

Stock Details

Ticker SymbolSWAV
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$17.00
CIK Code0001642545
CUSIP Number82489T104
ISIN NumberUS82489T1043
Employer ID27-0494101
SIC Code3845

Key Executives

NamePosition
Douglas E. Godshall M.B.A.President, Chief Executive Officer and Director
Isaac ZachariasChief Commercial Officer
Daniel HawkinsFounder and Senior Advisor
John M. AdamsCo-Founder and Technical Advisor
Renee M. GaetaChief Financial Officer
Luis MoralesSenior Vice President of Global Operations
Trinh PhungChief Accounting Officer, Principal Accounting Officer and Vice President of Finance
Debbie KasterVice President of Investor Relations
Hajime Tada J.D.General Counsel and Secretary
Robert FletcherSenior Vice President of Marketing and Market Access

Latest SEC Filings

DateTypeTitle
May 31, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
May 31, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
May 31, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
May 31, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
May 31, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
May 31, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
May 31, 2024POSASRFiling
May 31, 20248-KCurrent Report
May 31, 202425-NSEFiling
May 30, 20248-KCurrent Report